Cart
Orders
Not available hereProduct Overview
Huons Ascorbic Acid Inj. is a vitamin C injectable medicine containing 500 mg of ascorbic acid per 2 mL ampoule. The documented presentation contains 50 ampoules per box. Classified as a prescription medicine in South Korea, its Korean labeling includes prevention and treatment of vitamin C deficiency, including scurvy, in acute cases or when oral administration is difficult. These specifications support product assessment by professional buyers.
Key Features
- Vitamin C concentration: Each milliliter contains 250 mg of ascorbic acid.
- Ampoule presentation: Supplied as 2 mL ampoules in a documented 50-ampoule box configuration.
- Formulation appearance: Colorless to pale-yellow injectable liquid in a brown ampoule.
Composition & Specifications
| Specification | Product details |
|---|---|
| Product name | Huons Ascorbic Acid Inj. |
| Product category | Prescription vitamin C injectable medicine in South Korea |
| Active ingredient | Ascorbic acid (vitamin C) |
| Concentration | 250 mg/mL |
| Ampoule strength and volume | 500 mg per 2 mL ampoule |
| Packaging | 50 ampoules per box |
| Listed company | Huons Co., Ltd. |
| Listed contract manufacturer | Humedix Co., Ltd. |
| Declared excipients | Sodium bicarbonate, sodium bisulfite and water for injection |
The company and contract-manufacturer roles above reflect the Korean product record. Check the supplied carton and applicable product labeling when assessing a specific batch.
Storage & Handling
Store at 1–30°C in a light-protective, hermetically sealed container. The Korean product record specifies a shelf life of 36 months from manufacture; this does not indicate the remaining shelf life of supplied inventory. Follow the expiration date and storage instructions on the actual pack.
Frequently Asked Questions
Does Huons Ascorbic Acid Inj. contain a sulfite?
Yes. Sodium bisulfite is a declared excipient. Korean labeling warns of allergic reactions, including anaphylaxis and asthma reactions in susceptible patients. Qualified healthcare professionals should review the complete applicable labeling before use.
Does Korean prescription status establish eligibility to purchase in other countries?
No. Korean prescription classification does not establish authorization or supply eligibility in another jurisdiction. Professional buyers must confirm destination-country requirements and the applicable market-specific labeling.